AntriaBio Appoints Dr. Robert Bhisitkul to its Scientific Advisory Board
04. Oktober 2017 08:00 ET
|
AntriaBio, Inc.
LOUISVILLE, Colo., Oct. 04, 2017 (GLOBE NEWSWIRE) -- AntriaBio, Inc. (“The Company”) (OTCQB:ANTB), a biopharmaceutical company focused on developing platform technologies to target significant unmet...
AntriaBio and ActiveSite Pharmaceuticals Announce License and Development Agreement for Plasma Kallikrein Inhibitors
07. August 2017 08:00 ET
|
AntriaBio, Inc.
LOUISVILLE, Colo., Aug. 07, 2017 (GLOBE NEWSWIRE) -- AntriaBio, Inc. (“AntriaBio”) (OTCQB:ANTB) and ActiveSite Pharmaceuticals (“ActiveSite”) today announced that AntriaBio has exclusively licensed...